Triol caused reduction of Akt1, cyclin E2, cyclin B1, phospho-c-Myc Thr58/Ser62, c-Myc, and phospho-Akt Ser473 in all three prostate cancer cell lines. Here, MYC is linked to prostate carcinoma.